ÃÛÌÒ´«Ã½

We’re starting the final day of trading this week with a dive into the biggest pre-market stock movers for Friday!

Moving stocks this morning are earnings reports, clinical trial results, stock offerings, and more.

Let’s get into that news below!

Pre-ÃÛÌÒ´«Ã½ Stock Movers: 10 Top Gainers

1. Neptune Wellness Solutions (NASDAQ:NEPT) stock is rocketing more than 71% after releasing its .
2. Avalo Therapeutics (NASDAQ:AVTX) shares are soaring over 35% alongside heavy pre-market trading.
3. FLJ Group (NASDAQ:FLJ) stock is surging more than 19% without any clear news this morning.
4. Crown ElectroKinetics (NASDAQ:CRKN) shares are gaining over 17% on Friday morning.
5. Galmed Pharmaceuticals (NASDAQ:GLMD) stock is rising more than 16% despite a lack of news this morning.
6. Infinity Pharmaceuticals (NASDAQ:INFI) shares are increasing by over 13% this morning.
7. Alpha Tau Medical (NASDAQ:DRTS) stock is climbing more than 13% alongside .
8. Biolase (NASDAQ:BIOL) shares are jumping over 12% after .
9. Ebet (NASDAQ:EBET) stock is heading more than 11% higher as the company’s shares have been volatile this week.
10. Sangamo Therapeutics (NASDAQ:SGMO) shares are up close to 10% on Friday morning.

10 Top Losers

1. Farfetch (NYSE:FTCH) stock is crashing over 40% on a .
2. Athersys (NASDAQ:ATHX) shares are plummeting more than 29% after .
3. Recruiter.Com (NASDAQ:RCRT) stock is diving over 25% after .
4. CervoMed (NASDAQ:CRVO) shares are tumbling more than 23% after .
5. Eightco (NASDAQ:OCTO) stock is taking a nearly 23% beating on Friday morning.
6. Bone Biologics (NASDAQ:BBLG) shares are sliding over 15% this morning.
7. Predictive Oncology (NASDAQ:POAI) stock is dropping more than 15% following the .
8. BioNexus Gene Lab (NASDAQ:BGLC) shares are decreasing over 15% this morning.
9. F45 Training (NYSE:FXLV) stock is falling more than 13% alongside delisting plans.
10. Stronghold Digital Mining (NASDAQ:SDIG) shares close out our pre-market stock movers down over 11%.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.